Viridian Therapeutics, Inc. (VRDN)
14.80
+0.14
(+0.96%)
USD |
NASDAQ |
Apr 17, 16:00
14.82
+0.02
(+0.14%)
After-Hours: 20:00
Viridian Therapeutics SG&A Expense (Quarterly) : 33.67M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 0.8466M |
| Amgen, Inc. | 1.952B |
| Boston Scientific Corp. | 1.834B |
| Plus Therapeutics, Inc. | 4.168M |
| Nutriband, Inc. | 3.492M |